Investigating the effect of prednisolone in the bronchoscopic procedure in the treatment of patients with tracheal stenosis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230410057872N1

Enrollment

Registered

2023-04-26

Start date

2023-05-22

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tracheal stenosis.

Interventions

Intervention 1: Intervention group: patients who receive 0.5 mg/kg of prednisolone daily for 3 weeks after first-stage bronchoscopy. Intervention 2: Control group: Patients who undergo bronchoscopy wi

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Patients suffering from tracheal stenosis.2) Patients who have a stenosis equal to less than 1.5 cm.3) Patients who are candidates for rigid bronchoscopy

Exclusion criteria

Exclusion criteria: 1) Patients who are candidates for bronchoscopy due to other diseases (except for tracheal stenosis).2) Patients whose stenosis length is more than 1.5 cm.3) Patients suffering from underlying diseases for whom corticosteroid administration is contraindicated.

Design outcomes

Primary

Measure	Time frame
Treatment of tracheal stenosis. Timepoint: 3 weeks later (21 days). Method of measurement: Bronchoscopy.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Falah

Ghoum University of Medical Sciences

dr_fallah69@yahoo.com+98 25 3107 1100

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026